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Introduction 
 
This will not come as a great surprise to many readers, but it turns out that multi-national tobacco 
companies are not generous, kind-hearted or benevolent, and that any similarity they bear to boy 
scouts or fairy godmothers is dangerously misleading. The Framework Convention on Tobacco 
Control (FCTC) Conference of the Parties (COP), meeting last November in Durban, reminded 
us of these truths. It recognised that tobacco company corporate social responsibility (CSR), 
whether in the form of donations to charity, support for good causes or lavishly funded 
campaigns trumpeting their own virtuous behaviour, is in fact a self seeking marketing tool 
designed to win friends and influence people. It is as much part of ensnaring new generations of 
tobacco users as are cowboys and camels.  
 
This paper explains how CSR forms part of the tobacco industry‟s wider marketing strategy and, 
reassuringly, that the FCTC sees CSR for what it is.  
 
 
Business as Usual 
 
Tobacco control has long been sceptical about tobacco industry good deeds.  The obvious 
disconnect between ethical behaviour and selling an addictive, lethal product underpins what 
Chapman described as a “wholesale cynicism and disgust in health and medical circles” (p445)1.   
Similarly, albeit it in more measured tones, Hirschhorn warns against “the uncritical acceptance 
of the tobacco industry‟s mantle of social responsibility” (p452)2, pointing out that the already 
much sinned-against smoker is a key target of its disingenuous charm offences.   
 
More recently commentators have also emphasised that tobacco industry CSR is not just an 
oxymoron, but a powerful business tool.  Yang and Malone (p396)
3
, for example, point out that 
the PM „societal alignment‟ initiative was as much about shifting social norms to enable 
„business as usual‟  as vice versa.  It is also apparent that social responsibility initiatives have 
been used to exploit divisions in the tobacco control community
4
 especially in the areas of harm 
reduction
5
 and collaboration.  More recently still, Tesler and Malone show how one tobacco 
company has used “philanthropy strategically to improve company image, influence 
policymakers, and influence public health policies”6. 
 
It is apparent, then, that the key word in the phrase „corporate social responsibility‟ is „corporate‟ 
because the aim is to benefit the standing and success of the corporate sponsor. However good 
the cause, therefore, it is vital to identify the inevitable quid pro quo. In the case of the tobacco 
industry, the payback for CSR comes in respectability, legitimacy and the right to continue doing 
– and growing – its business. In other words the cost is more tobacco users, more addiction and 
more premature death.  
 
CSR is a subset of Stakeholder Marketing, which also takes in cause-related marketing (linking 
your company or product to a good cause) and corporate affairs (networking with stakeholders). 
These are the activities corporations – including multinational tobacco companies – engage in to 
manage their relationship with wider society. An Economist special report
7
 divides CSR into 
three layers: corporate philanthropy (giving to good causes of one sort or another); risk 
management (generosity after some reputation damaging event such as a lawsuit for smuggling 
or causing harm to consumers) and value creation (the strategic use of good behaviour to build 
competitive advantage).  
 
The same report goes on to specify the benefits of CSR, which include enhanced reputation, 
better staff recruitment and the avoidance of “heavy handed Government regulation”7. Similarly 
Noreena Hertz confirms that CSR‟s close cousin cause-related marketing “enhances corporate 
image, builds brands, generates PR and increases sales”8. The benefits then are considerable, 
but crucially they accrue to the corporation not society; the shareholder not the citizen. In a more 
truthful world, CSR would stand for Corporate Self Regard.  
 
The deployment of CSR is simply a recognition by business that it operates in a social context 
comprising political, regulatory, economic, technological and competitive forces and that there is 
much to be gained from making this environment as supportive as possible
9
. “Corporate social 
responsiveness”, therefore, “refers to the capacity of a corporation to respond to social 
pressure”10, not its capacity to do good.  
 
CSR is then a core part of the business process, which like all the other components, is 
deliberately designed to benefit the company and maximise shareholder value. Niall Fitzerald, 
former CEO of Unilever, leaves no doubt about this: “Corporate social responsibility is a hard-
edged business decision”. [We do it] “not because it is a nice thing to do or because people are 
forcing us to do it…” [but] “because it is good for our business”11. This fits with the fiduciary 
responsibility of the corporation, which gives paramount importance to the shareholder. When 
Milton Friedman famously maintained that “the social responsibility of business is to increase 
its profits” he was not making a debating point, he was stating a truism.  
 
 
The National Cancer Institute Monograph  
 
It is easy to forget these hard-edged realities when considering individual examples of CSR. 
Supporting literacy programmes in Brazil (Philip Morris), biodiversity in Bangladesh (BAT) and 
recycling in Burkina Faso (Imperial Tobacco) all seem to be self evidently desirable activities; 
how could anyone object to them?  
 
The latest National Cancer Institute (NCI) monograph (see Figure 1), however, shows how 
tobacco companies use these activities, just as they use other marketing activities, to promote 
tobacco. At the centre of the figure is mass media advertising, the most obvious of tobacco 
promotion tools. This is nested in a range of other communications activities such as PR and 
sports sponsorship, and the core consumer marketing functions of product development, pricing 
and distribution. These in turn mesh with stakeholder marketing and CSR - whether tobacco 
related such as youth prevention work, or more general as with literacy or recycling. The only 
difference between the conventional marketing at the centre of Figure 1 and CSR is that the 
former targets potential customers, while the latter is more concerned with stakeholders and 
potential regulators.  
 
Furthermore, consumer and stakeholder marketing combine to form a synergistic and carefully 
honed strategy whose core purpose is, again, to promote tobacco and enhance the success and 
profitability of the tobacco company.  
 
The impact of the three inner layers of tobacco promotion depicted in Figure 1 is well 
understood. The impact of stakeholder marketing and CSR has been less well researched and, 
until recently, largely overlooked by tobacco control
6
.  
 
 
Figure 1: The Role of CSR in Tobacco Promotion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: National Cancer Institute
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The FCTC Response 
 
Fortunately the FCTC is robust enough to take on CSR. Its definitions are admirably broad: 
„Tobacco advertising and promotion‟ it states comprises „any form of commercial 
communication, recommendation or action with the aim, effect or likely effect of promoting a 
tobacco product or tobacco use either directly or indirectly‟ and „tobacco sponsorship‟ is defined 
as „any form of contribution to any event, activity or individual with the aim, effect or likely 
effect of promoting a tobacco product or tobacco use either directly or indirectly‟ (Article 1).  
 
So the net is wide enough.  
 
Under Article 13 of the FCTC, the 161 Parties to the Convention have agreed to put in place a 
„comprehensive ban of all tobacco advertising, promotion and sponsorship‟ up to the full limits 
of their constitutions.  
 
So the net is strong enough.  
 
In November, the COP – the governing body of the FCTC, constituted by its 161 Parties – 
adopted guidelines for implementation of Article 13. These tackle CSR head on, recognising its 
true purpose and the harm it does to public health. Specifically they conclude that contributions 
by tobacco companies to other entities for „socially responsible causes‟ are in fact a form of 
sponsorship; and that the publicising of „socially responsible‟ business practices – such as good 
employee-employer relations or environmental stewardship – is just another variation on tobacco 
promotion. They therefore recommend that both be banned. 
 
So, most importantly of all, there is a willingness and clear commitment to use the net.  
 
 
Conclusion 
 
Tobacco companies exist to enrich their shareholders by selling tobacco. Everything they do is 
focussed on this goal - indeed as corporations they are legally obliged to make this their priority. 
So when they support good causes or fund youth prevention campaigns they do so not because 
they care, but because it helps their business. Tobacco industry corporate social responsibility is 
a confidence trick in the light and mild tradition, designed to hide malevolent purpose behind an 
attractive label.  
 
Thanks to the FCTC and the excellent work done in Durban this faux altruism should now 
become a thing of the past. 
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